Management of Reversed End Diastolic Flow
For pregnancies with fetal growth restriction and reversed end-diastolic flow in the umbilical artery, delivery should be considered at 30-32 weeks of gestation as long as fetal surveillance remains reassuring. 1
Surveillance Protocol
- Hospitalization is recommended when reversed end-diastolic flow (REDF) is detected in the umbilical artery 1
- Heightened surveillance with cardiotocography (CTG) should be performed at least 1-2 times per day 1
- Doppler assessment should be increased to 2-3 times per week when abnormal umbilical artery flow is detected 1, 2
- Regular amniotic fluid volume assessment (twice weekly) is recommended for pregnancies with abnormal umbilical artery Doppler findings 2
- Daily discussion with the consultant obstetrician about the clinical situation is essential 2
Antenatal Interventions
- Antenatal corticosteroids should be administered if reversed end-diastolic flow is noted at <34 weeks in a pregnancy with suspected intrauterine growth restriction (IUGR) 1
- Magnesium sulfate for fetal neuroprotection should be administered if delivery is planned before 32 weeks gestation 1, 2
Timing of Delivery
- Delivery at 30-32 weeks of gestation is recommended for pregnancies with fetal growth restriction and reversed end-diastolic flow 1
- This is a Level 1B recommendation according to the Society for Maternal-Fetal Medicine 1
- Earlier delivery may be indicated if there is:
- Poor interval fetal growth
- Deterioration of sonographic variables
- Abnormal cardiotocography 2
- Delaying delivery beyond the recommended gestational age increases the risk of adverse outcomes 2
Mode of Delivery
- Cesarean delivery should be considered for pregnancies with fetal growth restriction complicated by reversed end-diastolic velocity, based on the entire clinical scenario 1
- Studies show high rates of emergency cesarean section (80%) due to acute fetal distress in cases with REDF 3
Prognostic Implications
- Reversed end-diastolic flow is associated with significantly worse outcomes compared to absent end-diastolic flow:
- REDF represents an ominous finding that warrants urgent evaluation and intervention 5, 6
- Placental examination often reveals significant infarcts (80% of cases) 3
Clinical Pitfalls to Avoid
- Failing to differentiate between absent end-diastolic flow (delivery at 33-34 weeks) and reversed end-diastolic flow (delivery at 30-32 weeks) 1, 2
- Managing these high-risk cases without daily consultant involvement 2
- Delaying administration of corticosteroids, which should be given promptly when REDF is detected before 34 weeks 1
- Expectant management beyond recommended delivery timing, which has not shown benefits in terms of long-term morbidity 7